---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020357"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T05:28:23.528548+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs board authorizes exploring reverse merger with crypto-focused company and Bitcoin treasury

## Summary
- Board unanimously authorized exploring reverse merger with a digital asset-focused operating company (crypto treasury management).
- Board approved strategic treasury initiative to acquire and hold digital assets, including Bitcoin, for long-term value.
- No binding agreement yet; management will conduct diligence and evaluate shareholder interests.
- CEO cites goal to preserve existing asset value: Crown Medical Collections (up to $50M net), Nebula Genomics, BE-Smart test.
- Company is a biotech/genomics/consumer products firm considering a pivot into digital assets.

## SEC filing metadata
- accession: 0001641172-25-020357
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000164117225020357/0001641172-25-020357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000164117225020357/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020357
- JSON: https://secwatch.observer/filing/0001641172-25-020357.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020357.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.